Oral Oncol
-
Publication Venue For
- The relative distribution of oral cancer in the United States by subsite.. 89:56-58. 2019
- Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.. 85:8-14. 2018
- The risk of carotid stenosis in head and neck cancer patients after radiation therapy.. 80:9-15. 2018
- Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.. 62:11-19. 2016
- Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus.. 56:47-53. 2016
- Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.. 51:832-838. 2015
- HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.. 51:662-667. 2015
- Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.. 51:586-592. 2015
- Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma.. 50:848-856. 2014
- Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer.. 50:765-769. 2014
- ACR Appropriateness Criteria® thyroid carcinoma.. 50:577-586. 2014
- Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.. 49:1025-1031. 2013
- Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.. 48:1025-1030. 2012
- Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinoma.. 48:842-847. 2012
- ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.. 47:554-559. 2011